Suppr超能文献

吡嗪酰胺曼尼希碱的合成及其抗结核特性。

Synthesis of pyrazinamide Mannich bases and its antitubercular properties.

作者信息

Sriram Dharmarajan, Yogeeswari Perumal, Reddy Sushma Pobba

机构信息

Medicinal Chemistry Research Laboratory, Pharmacy group, Birla Institute of Technology and Science, Pilani 333031, India.

出版信息

Bioorg Med Chem Lett. 2006 Apr 15;16(8):2113-6. doi: 10.1016/j.bmcl.2006.01.064. Epub 2006 Feb 7.

Abstract

A series of pyrazinamide (PAZ) Mannich bases has been synthesized by reacting PAZ, formaldehyde, and various substituted piperazines using microwave irradiation with the yield ranging from 46% to 86%. The synthesized compounds were evaluated for antimycobacterial activity in vitro and in vivo against Mycobacterium tuberculosis H37Rv (MTB). Among the synthesized compounds, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-4-((pyrazine-2-carboxamido)methyl)piperazin-1-yl)-4-oxoquinoline-3-carboxylic acid (17) was found to be the most active compound in vitro with MIC of 0.39 and 0.2 microg/mL against MTB and multidrug-resistant MTB, respectively. In the in vivo animal model 17 decreased the bacterial load in lung and spleen tissues with 1.86 and 1.66-log10 protections, respectively.

摘要

通过微波辐射使吡嗪酰胺(PAZ)、甲醛与各种取代哌嗪反应,合成了一系列吡嗪酰胺(PAZ)曼尼希碱,产率在46%至86%之间。对合成的化合物进行了体外和体内抗结核分枝杆菌活性评估,以对抗结核分枝杆菌H37Rv(MTB)。在合成的化合物中,发现1-环丙基-6-氟-1,4-二氢-8-甲氧基-7-(3-甲基-4-((吡嗪-2-甲酰胺基)甲基)哌嗪-1-基)-4-氧代喹啉-3-羧酸(17)是体外活性最强的化合物,对MTB和耐多药MTB的最低抑菌浓度分别为0.39和0.2微克/毫升。在体内动物模型中,化合物17分别使肺和脾组织中的细菌载量降低了1.86和1.66个对数10级。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验